ActHIB Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
Conditions: Poliomyelitis; Diphtheria; Haemophilus Influenzae Type b; Tetanus; Acellular Pertussis; Hepatitis BInterventions: Biological: Infanrix hexa; Biological: Pediarix; Biological: ActHIB; Biological: Pentacel; Biological: Engerix-B; Biological: Infanrix; Biological: Hiberix; Biological: Prevnar13; Biological: RotarixSponsor: GlaxoSmithKlineRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2014 Category: Research Source Type: clinical trials

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
Conditions: Poliomyelitis; Diphtheria; Haemophilus Influenzae Type b; Tetanus; Acellular Pertussis; Hepatitis BInterventions: Biological: Infanrix hexa; Biological: Pediarix; Biological: ActHIB; Biological: Pentacel; Biological: Engerix-B; Biological: Infanrix; Biological: Hiberix; Biological: Prevnar13; Biological: RotarixSponsor: GlaxoSmithKlineActive, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2014 Category: Research Source Type: clinical trials

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
Conditions: Poliomyelitis; Diphtheria; Haemophilus Influenzae Type b; Tetanus; Acellular Pertussis; Hepatitis BInterventions: Biological: Infanrix hexa; Biological: Pediarix; Biological: ActHIB; Biological: Pentacel; Biological: Engerix-B; Biological: Infanrix; Biological: Hiberix; Biological: Prevnar13; Biological: RotarixSponsor: GlaxoSmithKlineActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2014 Category: Research Source Type: clinical trials

Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers
Condition: Pneumonia, PneumococcalInterventions: Biological: PATH-wSP; Biological: pneumococcal polysaccharide conjugate vaccine (adsorbed); Biological: Diptheria Pertussis Tetanus Hep B Haemophilus b Conjugate; Other: SalineSponsor: PATHRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2014 Category: Research Source Type: clinical trials

Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers
Condition: Pneumonia, PneumococcalInterventions: Biological: PATH-wSP; Biological: pneumococcal polysaccharide conjugate vaccine (adsorbed); Biological: Diptheria Pertussis Tetanus Hep B Haemophilus b Conjugate; Other: SalineSponsor: PATHRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2014 Category: Research Source Type: clinical trials

Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Condition: Haemophilus Influenzae Type bInterventions: Biological: GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108); Biological: ActHIB™; Biological: Pentacel™; Biological: Pediarix™; Biological: Prevnar 13™; Biological: Rotarix™; Biological: Engerix™-B; Biological: Infanrix™Sponsor: GlaxoSmithKlineCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2009 Category: Research Source Type: clinical trials

Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Condition: Haemophilus Influenzae Type bInterventions: Biological: GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108); Biological: ActHIB™; Biological: Pentacel™; Biological: Pediarix™; Biological: Prevnar 13™; Biological: Rotarix™; Biological: Engerix™-B; Biological: Infanrix™Sponsor: GlaxoSmithKlineCompleted - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2009 Category: Research Source Type: clinical trials